Cargando…
The use of sibutramine in the management of obesity and related disorders: An update
AIMS: To review the major trials that evaluated the efficacy and safety of the use of sibutramine for weight loss and the impact of this agent on obesity-related disorders. METHODS AND RESULTS: The most important articles on sibutramine up to January 2009 were located by a PubMed and Medline search....
Autores principales: | Tziomalos, Konstantinos, Krassas, Gerasimos E, Tzotzas, Themistoklis |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686261/ https://www.ncbi.nlm.nih.gov/pubmed/19475780 |
Ejemplares similares
-
The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease
por: Krassas, Gerasimos E, et al.
Publicado: (2007) -
Phentermine, Sibutramine and Affective Disorders
por: An, Hoyoung, et al.
Publicado: (2013) -
Prevalence and geographic variation of abdominal obesity in 7- and 9-year-old children in Greece; World Health Organization Childhood Obesity Surveillance Initiative 2010
por: Hassapidou, Maria, et al.
Publicado: (2017) -
Sibutramine on Cardiovascular Outcome
por: Scheen, André J.
Publicado: (2011) -
Sibutramine-induced mania as the first manifestation of bipolar disorder
por: Waszkiewicz, Napoleon, et al.
Publicado: (2012)